OTCMKTS:PHMMF Pharma Mar (PHMMF) News Today $41.21 0.00 (0.00%) (As of 05/26/2023) Add Compare Share Share Today's Range$41.21▼$41.2150-Day Range$41.21▼$69.4052-Week Range$41.21▼$79.38Volume13 shsAverage Volume29 shsMarket Capitalization$742.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest Get Pharma Mar News Delivered to You Automatically Sign up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter. Email Address PHMMF Media Mentions By Week PHMMF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHMMF News Sentiment▼0.000.78▲Average Medical News Sentiment PHMMF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHMMF Articles This Week▼00▲PHMMF Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNEEDHAM & COMPANY INC. Maintains Pharma Mar (XMAD:PHM) Buy Recommendationmsn.com - April 22 at 8:50 AMPharma Mar (OTCMKTS:PHMMF) Hits New 12-Month Low at $47.70americanbankingnews.com - March 29 at 7:00 AMPharmaceutical Excipients Market Top Players By 2031marketwatch.com - March 27 at 8:51 AMPharmaceutical company to open in McHenrynews.yahoo.com - March 25 at 8:48 AMInnate Pharma (IPHA) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - March 24 at 7:39 AMBig Pharma companies back new startup out of Mass General Brighambizjournals.com - March 16 at 8:33 PMPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023markets.businessinsider.com - November 9 at 2:50 AMEuropean Commission suspects pharma group Teva broke antitrust rulesyahoo.com - October 10 at 5:51 AMPharmacists Database List of Emails, Phone Numbers, Contact Informationapnews.com - August 30 at 2:21 AMLife Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variantsfinance.yahoo.com - January 11 at 12:42 PMPharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwanfinanznachrichten.de - November 11 at 11:23 AMSpain's PharmaMar posts 58% drop in 9-mth profit despite higher revenuesnews.yahoo.com - October 28 at 5:34 PMSpain's PharmaMar nine-month net profit falls 58%reuters.com - October 28 at 12:32 PMSpain's PharmaMar sales rise on demand for cancer treatmentsnasdaq.com - July 29 at 2:35 PMSpain's PharmaMar says COVID-19 treatment shows clinical efficacy in trialsreuters.com - May 26 at 7:19 AMPharma Mar SAU (PHMR)investing.com - April 30 at 1:20 PMSpain's regulator lets PharmaMar test treatment on COVID-19 patientsreuters.com - April 29 at 3:32 PMUPDATE 2-PharmaMar soars 21% after journal Science confirms drug's efficacy against COVIDcn.reuters.com - January 27 at 7:52 AMScience Magazine confirms efficacy of PharmaMar's Plitidepsin against COVID-19reuters.com - January 26 at 2:45 PMUPDATE 1-PharmaMar says paper in journal Science confirms vaccine efficacyreuters.com - January 26 at 9:44 AMPharma Mar SA Bearer Shs Stock , PHMMFmarkets.businessinsider.com - December 28 at 11:12 PMAmicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.1%nasdaq.com - December 15 at 12:36 PMCambio en el Ibex: PharmaMar ocupará el puesto de Ence el 21 de septiembremsn.com - September 11 at 3:14 AMPharma Mar, S.A. (PHMMF)finance.yahoo.com - May 26 at 7:34 PMPharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19finance.yahoo.com - April 28 at 7:37 AMThe Pharma Mar (BME:PHM) Share Price Is Up 157% And Shareholders Are Boasting About Itfinance.yahoo.com - March 21 at 8:39 AMSpain's PharmaMar receives CE approval for coronavirus diagnostic kitswww.lse.co.uk - March 6 at 2:05 PMPharmaMar shares jump after coronavirus diagnosis kit gets EU certificationuk.reuters.com - March 6 at 9:04 AMFDA accepts PharmaMar's lurbinectedin application for lung cancerseekingalpha.com - February 18 at 9:07 AMPharmaMar and Jazz Pharmaceuticals Announce FDA...www.benzinga.com - February 17 at 7:42 AMAnalysts Expect Breakeven For Pharma Mar, S.A. (BME:PHM)finance.yahoo.com - January 21 at 7:22 AMAre Insiders Buying Pharma Mar, S.A. (BME:PHM) Stock?finance.yahoo.com - December 6 at 9:04 AMDoes Pharma Mar, S.A. (BME:PHM) Have A High Beta?finance.yahoo.com - October 1 at 8:43 AMPharma Mar (BME:PHM) Is Making Moderate Use Of Debtfinance.yahoo.com - August 29 at 6:24 PMGlobal Dermal Filler Medical Devices Pipeline Assessment 2019: Products Under Development, Companies & Products, and Recent Developments - ResearchAndMarkets.com - Business Wirewww.businesswire.com - February 25 at 6:10 PM Get Pharma Mar News Delivered to You Automatically Sign up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACBFF News OXBDF News SEIGY News CLIGF News ZLDPF News NHNKY News AVXL News ARCT News IMTX News PROG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (OTCMKTS:PHMMF) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.